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S U M M A R Y
We report the ﬁrst case in the English language literature, to our knowledge, of native valve endocarditis
due to Legionella pneumophila. The patient had no prior history of cardiothoracic intervention or
congenital valvular process. A transesophageal echocardiogram showed a vegetation on the aortic valve.
Blood culture and bronchoalveolar lavage returned positive for L. pneumophila. The patient was treated
with levoﬂoxacin for 6 weeks total after a second set of blood cultures were negative. The patient
survived a complicated hospital course and was discharged to a rehabilitation facility.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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The incidence of community-acquired native valve endocarditis
ranges from 1.7 to 6.2 cases per 100 000 person-years in the USA
and western Europe.1 Meanwhile, prosthetic valve endocarditis
comprises from 7% to 25% of all cases of infective endocarditis in
developed countries.1 Previously reported cases of Legionella
species endocarditis have all occurred after cardiothoracic
intervention with prosthetic or homograft valve placement. We
report what we believe to be the ﬁrst case of Legionella species
native valve endocarditis without any prior history of cardiotho-
racic intervention.
2. Case report
A 42-year-old woman who worked at a construction site, who
had been discharged from a hospital on oral corticosteroids due to
a clinical diagnosis of hypersensitivity pneumonitis 2 weeks prior
to this admission, returned to the emergency department with the
complaint of generalized weakness and shortness of breath. On
arrival, the patient was hypotensive with a blood pressure of 77/
42 mmHg, tachycardic at 120 beats per min, and tachypneic at 32
breaths per min, with an oxygen saturation of 78% on room air. The
patient was initially afebrile. She continued to deteriorate and was
subsequently intubated for respiratory failure. She was volume
resuscitated and then placed on norepinephrine secondary to
refractory hypotension.* Corresponding author.
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3.7  109 leukocytes/l with bands of 45% and an anion gap metabolic
acidosis. Her platelet count was 151  109 platelets/l with a
hemoglobin of 12.2 g/dl. A chest radiograph revealed diffuse
bilateral pulmonary opacities. After obtaining blood, urine, and
respiratory cultures, broad-spectrum antibiotics were initiated with
piperacillin/tazobactam, vancomycin, amikacin, and azithromycin.
Initial microbiological studies including blood cultures, as well as
bronchoalveolar lavage (BAL), were negative, except for a Legionella
urine direct ﬂuorescence antigen (DFA) test, which returned as
positive. An HIV test was negative. Transthoracic echocardiography
was performed, which revealed a non-mobile irregularity on the
right coronary leaﬂet of the aortic valve. Rifampin was added to the
antibiotic regimen as a result of clinical deterioration. Subsequently
a transesophageal echocardiogram was performed, which revealed a
0.6  1.0 cm vegetation on the right coronary leaﬂet of the aortic
valve. The patient was continued on broad-spectrum antibiotics for
culture-negative endocarditis. Due to the positive Legionella urine
antigen and the ﬁnding of a valvular vegetation, a special request
was made to microbiology for subculturing of the blood cultures
onto buffered charcoal yeast extract (BCYE) agar.
After 2 weeks of hospitalization, blood cultures and BAL
cultures returned as positive for Legionella pneumophila. The L.
pneumophila isolated from BAL was then conﬁrmed by polymerase
chain reaction by the state health department as L. pneumophila
serogroup 1. The patient’s antibiotics were deescalated to
levoﬂoxacin and rifampin and ﬁnally to levoﬂoxacin alone for a
total of 6 weeks after repeat blood cultures were negative. After 3
weeks of treatment, a repeat transesophageal echocardiogram
revealed resolution of the aortic valve vegetation. After a
prolonged hospital course, which involved acute respiratoryses. Published by Elsevier Ltd. All rights reserved.
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shock, and acute kidney injury requiring hemodialysis, the patient
was transferred from the medical intensive care unit to the general
medical wards and ultimately to a rehabilitation facility.
3. Discussion
L. pneumophila is a Gram-negative facultative intracellular
bacterium that is associated with both community-acquired and
nosocomial pneumonia and rarely extrapulmonary disease.2 There
are more than 70 serogroups in the Legionella family, with L.
pneumophila serotypes 1–6 accounting for the majority of human
infections.3 Legionella species infections are commonly associated
with outbreaks as a result of exposure to contaminated water
systems. Due to the intracellular nature of this organism, as well as
the inability of commercial automated blood culture systems to
detect growth below a predetermined threshold, a special medium
known as BCYE agar is needed for diagnosis.4 It takes approxi-
mately 3 days for Legionella to grow on solid medium, but certain
species may take up to 2 weeks to develop perceptible colonies.
Legionella endocarditis is distinctly uncommon. Generally, the
clinical presentation includes fever, mild congestive heart failure,
and vegetations on echocardiogram. These individuals usually
have an underlying condition, such as a valvular prosthesis, prior
cardiothoracic surgery, or rheumatic fever. Legionella endocarditis
has been associated with normal leukocyte counts and thrombo-
cytopenia, as well as anemia. However, embolic phenomena havenot been associated with Legionella endocarditis.4 In the current
English language literature there are 12 reported cases of
Legionella endocarditis. Eleven cases are associated with pros-
thetic valves, while one is associated with a homograft valve.5
However, our patient had no history of prosthetic valves, surgical
interventions, or congenital valvular disease. Apparently, the only
risk factor for our patient was immunosuppression with steroids
and possible exposure at her place of work. To our knowledge, this
is the ﬁrst person in the literature determined to have L.
pneumophila native valve endocarditis resulting from Legionella
pneumonia without prior history of cardiothoracic intervention.
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